PositiveID has received US Food and Drug Administration (FDA) clearance for its iglucose mobile health system for diabetes management.
The system collects and transmits stored data from several FDA-cleared blood glucose meters to a secure database using wireless cellular technology.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
PositiveID CEO William Caragol said that iglucose is a safe, flexible, convenient, cost-effective and straightforward solution that helps reduce costs to the healthcare system while improving disease management and patient compliance.
The company plans to initiate commercialisation of the device in the first quarter of 2012.
